Black Rock Inc. Idera Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.23 - $0.43 $42 - $79	-185 Reduced 0.04%	439,456 $153,000
Q3 2022 Nov 14, 2022	SELL	$0.38 - $0.53 $109 - $152	-287 Reduced 0.07%	439,641 $164,000
Q2 2022 Aug 12, 2022	SELL	$0.32 - $0.74 $36,950 - $85,447	-115,469 Reduced 20.79%	439,928 $202,000
Q1 2022 May 12, 2022	SELL	$0.41 - $0.7 $2,284 - $3,899	-5,571 Reduced 0.99%	555,397 $277,000
Q4 2021 Feb 10, 2022	BUY	$0.53 - $1.03 $3,331 - $6,473	6,285 Added 1.13%	560,968 $320,000
Q3 2021 Nov 09, 2021	SELL	$1.0 - $1.18 $2,217 - $2,616	-2,217 Reduced 0.4%	554,683 $572,000
Q2 2021 Aug 11, 2021	BUY	$1.01 - $1.58 $562,469 - $879,902	556,900 New	556,900 $668,000

Ticker IDRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,296,900
Market Cap $188M
Description
Idera Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for rare disease indications in the United States. It offers Tilsotolimod (IMO-2125), a synthetic phosphorothioate oligonucleotide that acts as a direct agonist of TLR9 to stimulate the immune systems and for treating s...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.